We only have this paper's title and publication details.
Read it at the sourceEvaluates safety and tolerability of Lu AG09222 with ubrogepant in migraine participants, suggesting a combination approach for treatment.
To evaluate the safety and tolerability of Lu AG09222 when co-administered with ubrogepant.
No takes yet. Share an insight, caveat, or question.
Starling et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: